NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ:NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nutex and certain of its officers and/or […]

BALTIMORE, Aug. 07, 2025 (GLOBE NEWSWIRE) — The American Urological Association (AUA) and the Urology Care Foundation, the official foundation of the AUA, are pleased to recognize 12 researchers as recipients of the 2025 Urology Care Foundation Research Scholar Awards. Research Scholar Awards support future research leaders and ensure they receive the necessary training and

2025 Urology Care Foundation Research Scholar Awardees Announced GlobeNewswire August 07, 2025 BALTIMORE, Aug. 07, 2025 (GLOBE NEWSWIRE) — The American Urological Association (AUA) and the Urology Care Foundation, the official foundation of the AUA, are pleased to recognize 12 researchers as recipients of the 2025 Urology Care Foundation Research Scholar Awards. Research Scholar Awards

Deal expands The Bonadio Group’s Capital Regional footprint and strengthens the firm’s outsourced accounting and small business advisory services ROCHESTER, NY / ACCESS Newswire / August 7, 2025 / The Bonadio Group, a nationally ranked IPA Top 50 CPA firm and the largest independent provider of accounting, assurance, tax, and consulting and advisory services in

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether agilon and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Duolingo, Inc. ("Duolingo" or the "Company") (NASDAQ:DUOL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Duolingo and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE:MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Molina and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Charter Communications, Inc. ("Charter" or the "Company") (NASDAQ:CHTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Charter and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ("Praxis" or the "Company") (NASDAQ:PRAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Praxis and certain of its officers

NEW YORK, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ:CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Confluent and certain of its officers and/or directors have